Most Read Articles
Stephen Padilla, 03 Feb 2020
Treatment with semaglutide leads to clinically significant decreases in haemoglobin A1C (HbA1c) and body weight in patients with type 2 diabetes (T2D) across the SUSTAIN 1–7 trials, regardless of race and ethnicity, results of a posthoc analysis have shown.
Roshini Claire Anthony, 4 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

6 days ago
Eating behaviours have been shown to moderate the relationship between cumulated risk factors in the first 1,000 days and adiposity outcomes at 6 years of age, which underscores modifiable behavioural targets for interventions, reports a study.
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.

Optimizing outcomes when reversing neuromuscular block following surgery: Expert case discussions

15 May 2020
Neuromuscular block (NMB) is an essential part of surgery.However, effective reversal of NMB following surgery is necessaryto assist recovery and avoid serious complications associated withresidual blockade. The cases presented here outline the potentialbenefits of using sugammadex for NMB reversal.


Sponsored as a service to the medical profession by MSD.
MERCK SHARP & DOHME (ASIA) LTD.
27/F, Lee Garden Two, 28 Yun Ping Road, Causeway Bay, Hong Kong.
TEL: (852) 3971 2800
FAX: (852) 2834 0756
Website: www.msd.com.hk
This information is provided as a professional service by Merck Sharp & Dohme (Asia) Ltd. The views expressed in the publication reflect the experience and opinions of the authors. For any product mentioned in this publication, the prescribing information from the company (manufacturer) should be consulted prior prescribing.
HK-XBR-00017 03/20
Copyright © 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.



Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 03 Feb 2020
Treatment with semaglutide leads to clinically significant decreases in haemoglobin A1C (HbA1c) and body weight in patients with type 2 diabetes (T2D) across the SUSTAIN 1–7 trials, regardless of race and ethnicity, results of a posthoc analysis have shown.
Roshini Claire Anthony, 4 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

6 days ago
Eating behaviours have been shown to moderate the relationship between cumulated risk factors in the first 1,000 days and adiposity outcomes at 6 years of age, which underscores modifiable behavioural targets for interventions, reports a study.
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.